Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Theraclion SA (TCLIF) Price & Analysis

TCLIF Stock Chart & Stats

$0.53$0.00(0.00%)
At close: 4:00 PM EDT
$0.5$0.525$0.5513 Apr20 Apr27 Apr4 May
Day’s Range
$0.53 - $0.53
52-Week Range
$0.32 - $0.53
Previous Close
$0.53
Volume
500
Average Volume (3M)
0
Market Cap
$57.87M
Enterprise Value
$45.63M
Total Cash (Recent Filing)
$5.22M
Total Debt (Recent Filing)
$4.95M
Price to Earnings (P/E)
―
Beta
0.00
Next Earnings
Apr 29, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Non-invasive Therapeutic Technology

Theraclion’s focus on non-invasive, image-guided treatment addresses procedures where avoiding surgery may be clinically valuable. A specialized technology platform in established thyroid and breast indications can support durable differentiation and continued commercialization as provider adoption develops.

Recurring Revenue Opportunities

The business model extends beyond one-time system sales through procedure-linked consumables and service contracts. If installed systems expand, these recurring elements can improve revenue visibility, deepen provider relationships, and create additional monetization from each treatment platform.

Reported EPS Improvement

Reported positive EPS growth indicates some year-over-year improvement in per-share earnings metrics, even though the company remains loss-making. Continued improvement could eventually support operating leverage, but the evidence currently represents progress rather than established profitability.

Bears Say

Persistent Unprofitable Operations

Persistent losses across gross, operating, and net levels show that the current revenue base does not support the cost structure. Without a sustained improvement in revenue or margins, profitability remains structurally unresolved and may continue consuming capital over the next several quarters.

Ongoing Cash Burn

Consistently negative operating and free cash flow means the business is not yet funding operations internally. The approximately €7.2M 2025 cash outflow indicates continued dependence on external funding, reducing flexibility to invest, absorb setbacks, or scale independently.

Negative Equity And Meaningful Debt

Recurring negative equity signals that past losses have eroded the capital base, while debt is substantial relative to annual revenue. This combination raises solvency and financing risk, limits financial flexibility, and can constrain the company’s ability to fund growth without additional capital.

Theraclion SA News

TCLIF FAQ

What was Theraclion SA’s price range in the past 12 months?
Theraclion SA lowest stock price was $0.32 and its highest was $0.53 in the past 12 months.
What is Theraclion SA’s market cap?
Theraclion SA’s market cap is $57.87M.
When is Theraclion SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theraclion SA’s earnings last quarter?
Theraclion SA released its earnings results on Sep 16, 2026. The company reported -$0.056 earnings per share for the quarter.
Is Theraclion SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Theraclion SA pay dividends?
Theraclion SA does not currently pay dividends.
What is Theraclion SA’s EPS estimate?
Theraclion SA’s EPS estimate for its next earnings report is not yet available.
What happened to Theraclion SA’s price movement after its last earnings report?
Theraclion SA reported an EPS of -$0.056 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Theraclion SA?
Currently, no hedge funds are holding shares in TCLIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology